Dresden Neurovascular Center, Department of Neurology, Medical Faculty and University Hospital Carl Gustav Carus Dresden University of Technology Dresden Germany.
Division of Health Care Sciences Dresden International University Dresden Germany.
J Am Heart Assoc. 2024 Mar 19;13(6):e031854. doi: 10.1161/JAHA.123.031854. Epub 2024 Mar 8.
We studied the association of bridging intravenous thrombolysis (IVT) before thrombectomy for anterior circulation large-vessel occlusion and functional outcome and scrutinized its dependence on grade of reperfusion and distal thrombus migration.
We included consecutive patients with anterior circulation large-vessel occlusion from our prospective registry of thrombectomy-eligible patients treated from January 1, 2017 to January 1, 2023 at a tertiary stroke center in Germany in this retrospective cohort study. To evaluate the association of bridging IVT and functional outcome quantified via modified Rankin Scale score at 90 days we used multivariable logistic and lasso regression including interaction terms with grade of reperfusion quantified via modified Thrombolysis in Cerebral Infarction (mTICI) scale and distal thrombus migration adjusted for demographic and cardiovascular risk profiles, clinical and imaging stroke characteristics, onset-to-recanalization time and distal thrombus migration. We performed sensitivity analysis using propensity score matching. In our study population of 1000 thrombectomy-eligible patients (513 women; median age, 77 years [interquartile range, 67-84]), IVT emerged as a predictor of favorable functional outcome (modified Rankin Scale score, 0-2) independent of modified mTICI score (adjusted odds ratio, 0.49 [95% CI, 0.32-0.75]; =0.001). In those who underwent thrombectomy (n=812), the association of IVT and favorable functional outcome was reproduced (adjusted odds ratio, 0.49 [95% CI, 0.31-0.74]; =0.001) and was further confirmed on propensity score analysis, where IVT led to a 0.35-point decrease in 90-day modified Rankin Scale score (ß=-0.35 [95 CI%, -0.68 to 0.01]; =0.04). The additive benefit of IVT remained independent of modified mTICI score (ß=-1.79 [95% CI, -3.43 to -0.15]; =0.03) and distal thrombus migration (ß=-0.41 [95% CI, -0.69 to -0.13]; =0.004) on interaction analysis. Consequently, IVT showed an additive association with functional outcome in the subpopulation of patients undergoing thrombectomy who achieved successful reperfusion (mTICI ≥2b; ß=-0.46 [95% CI, -0.74 to -0.17]; =0.002) and remained beneficial in those with unsuccessful reperfusion (mTICI ≤2a; ß=-0.47 [95% CI, -0.96 to 0.01]; =0.05).
In thrombectomy-eligible patients with anterior circulation large-vessel occlusion, IVT improves functional outcome independent of grade of reperfusion and distal thrombus migration.
我们研究了前循环大血管闭塞患者血管内溶栓桥接治疗与功能结局的相关性,并仔细研究了其与再灌注程度和远端血栓迁移的关系。
我们在德国的一家三级卒中中心,从 2017 年 1 月 1 日至 2023 年 1 月 1 日期间,连续纳入了我们的血栓切除术合格患者前瞻性登记中的前循环大血管闭塞患者,进行了这项回顾性队列研究。为了评估桥接 IVT 与功能结局的相关性,我们使用多变量逻辑回归和套索回归,并纳入了改良 Thrombolysis in Cerebral Infarction (mTICI) 分级和远端血栓迁移的交互项,校正了人口统计学和心血管风险特征、临床和影像学卒中特征、发病到再通时间和远端血栓迁移。我们使用倾向评分匹配进行了敏感性分析。在我们的 1000 名血栓切除术合格患者(513 名女性;中位数年龄为 77 岁[四分位距,67-84])中,IVT 是功能结局良好(改良 Rankin 量表评分 0-2)的独立预测因素,与改良 mTICI 评分无关(调整后的优势比,0.49 [95%置信区间,0.32-0.75];=0.001)。在接受了血栓切除术的患者(n=812)中,IVT 与良好的功能结局相关(调整后的优势比,0.49 [95%置信区间,0.31-0.74];=0.001),并且在倾向评分分析中得到了进一步证实,其中 IVT 导致 90 天改良 Rankin 量表评分降低 0.35 分(β=-0.35 [95%置信区间,-0.68 至 0.01];=0.04)。IVT 的附加获益仍然独立于改良 mTICI 评分(β=-1.79 [95%置信区间,-3.43 至 -0.15];=0.03)和远端血栓迁移(β=-0.41 [95%置信区间,-0.69 至 -0.13];=0.004),交互分析显示。因此,在达到成功再灌注(mTICI≥2b)的血栓切除术患者亚组中,IVT 与功能结局具有附加相关性(β=-0.46 [95%置信区间,-0.74 至 -0.17];=0.002),在再灌注失败(mTICI≤2a)的患者中仍具有获益(β=-0.47 [95%置信区间,-0.96 至 0.01];=0.05)。
在前循环大血管闭塞的血栓切除术合格患者中,IVT 可改善功能结局,独立于再灌注程度和远端血栓迁移。